Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Abstract Background In January 2017, the Dutch cervical cancer screening programme
transitioned from cytomorphological to primary high-risk HPV (hrHPV) DNA screening …

Background The COVID-19 pandemic has disrupted cervical cancer screening services.
Assuming increases to screening capacity are unrealistic, we propose two recovery …

Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

Background Due to the arrival of multi-valent HPV vaccines, it is more and more important to
have a better understanding of the relationship between vaccination and screening …

Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …

Introduction In England, routine invitations for cervical screening were reduced between
April 2020 and June 2020 due to the COVID-19 pandemic. We quantify the impact of COVID …

Background Several countries have implemented vaccination against human papillomavirus
(HPV) for adolescent girls and must decide whether and how to adapt cervical cancer (CC) …

Women vaccinated against HPV16/18 are approaching the age for cervical screening;
however, an updated screening algorithm has not been agreed. We use a microsimulation …